Why Is Renalytix Stock Trading Higher Today? - Renalytix (NA

Renalytix receives U.S. Government approval for kidneyintelX.dkd inclusion in a 10-year contract for early-stage kidney disease testing services at $950 per result. Medicare coverage pending final policy approval.

Related Keywords

United States , , Us Veterans Administration , Department Of Defense , Centers For Medicare , Medicaid Services Clinical Lab Fee Schedule , National Government Services , Services Administration , United States Government , Novo Marketing , Governmentwide Acquisition Contract , General Services Administration , Medicare Administrative Contractor , Open Public Meeting , Local Coverage Determination , Medicaid Services Clinical Lab Fee ,